4/A: Charles River Labs Executive Birgit Girshick Reports Stock Transactions

Birgit Girshick, Corporate Executive VP & COO of Charles River Laboratories, reports acquisition and disposal of common stock related to performance share unit awards.

Summary

• Birgit Girshick, a Corporate Executive VP & COO at Charles River Laboratories International, Inc. [CRL], filed an amendment to a Form 4 regarding changes in beneficial ownership.
• The earliest transaction date reported is January 29, 2024.
• The report details the acquisition of 3,451 shares of common stock at $0 following the achievement of performance goals from performance share unit awards granted on May 28, 2021.
• Girshick also disposed of 1,135 shares of common stock at a price of $220.28.
• Following these transactions, Girshick beneficially owns 48,064 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing of stock transactions by an executive. The acquisition due to performance goals is mildly positive, while the disposal is mildly negative, balancing out to a neutral score.

Positives

• The acquisition of shares indicates the achievement of performance goals, which could be viewed positively.

Negatives

• The disposal of 1,135 shares could be interpreted negatively, although it's a relatively small portion of Girshick's total holdings.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which is crucial for investor confidence and market integrity.

Stakeholder Impact

• The filing provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates